Implantable Injection Port in Malignant Bone and Soft Tissue Tumors.

Endoprosthetic reconstruction for malignant bone and soft-tissue tumors.

BACKGROUND Nowadays, the results of the management of malignant bone and soft-tissue tumors have been dramatically improved because of the advance in imaging, chemotherapy, radiation therapy, and surgical techniques. Patients can have longer survival times with limb-salvage surgery. Several techniques of reconstruction have been advocated and gained more popularity following malignant tumor res...

Prevalence of Malignant Soft Tissue Tumors inExtremities: An Epidemiological Study in Syria

Background:   Although the majority of soft tissue masses are benign, it is important to consider malignancy in differential diagnoses. Because most soft tissue sarcomas present as a painless mass, clinicians must watch for signs suggestive of malignancy, including large size, rapid growth, and site deep into the deep fascia.The purpose of this study was to determine the relative prevalence acc...

Cytopathology of soft tissue and bone tumors.

Follow up what we will offer in this article about cytopathology of soft tissue and bone tumors. You know really that this book is coming as the best seller book today. So, when you are really a good reader or you're fans of the author, it does will be funny if you don't have this book. It means that you have to get this book. For you who are starting to learn about something new and feel curio...

Molecular markers in benign and malignant soft tissue tumors

Absence of Telomerase Activity in Malignant Bone Tumors and Soft-Tissue Sarcomas

PURPOSE Telomerase activity appears to play a crucial role in the development of many tumors. More than 80% of all malignant human tumors show an increased telomerase activity. However, conflicting results have been reported about telomerase activity in sarcomas. The aim of the study was to obtain more information about telomerase activity in sarcomas based on a large number of cases. METHODS...